Occurrence of ureaplasma urealyticum and mycoplasma hominis in Egyptian schistosomal patients with urinary tract infections cancer bladder and urinary stones

ABSTRACT

The present study was done to elucidate the role of Ureaplasma urealyticum [U. urealyticum] and Mycoplasma hominis [M. hominis] in Egyptian schistosomal patients with urinary tract infections [UT1], cancer bladder and urinary stones. Four groups were studied, the first included 40 male patients with simple urinary schistosomiasis, the second and third groups [30 patients each] included schistosomal patients complicated with urinary stones and cancer bladder respectively, while the fourth group included 40 normal subjects as controls. Mid stream urine, bladder urine and stones in the second group were tested for M. hominis and U. urealyticum by culture on A[7] agar, U[9] broth, mycoplasma agar, mycoplasma broth and inoculation into Mycofast All-In. U. urealyticum and M. hominis were isolated from both mid stream and bladder urine samples in patients with urinary. stones in 23.3%. In cancer bladder patients 13.3% were positive, while patients with simple urinary schistosomiasis were positive in 17.5%. Stone culture revealed 20% positivity. In the contorl group only mid stream urine revealed 7.5% positivity. Comparing the results obtained on A[7] agar, U[9] broth and mycoplasma agar and broth [classic ordinary culture media for mycoplasmas] with those obtained by Mycofast All in method, same results were obtained. The current work revealed that mycoplasmas may be regarded as a considerable aetiological agents in urinary tract infections especially in patients complicated with cancer bladder, urinary schistosomiasis and urinary stones which necessitates proper indentification and treatment. The Mycofast All-In test may be used as an alternative rapid and easy method for diagnosis of mycoplasmas